+1 888-880-9539News by Industry
Biotechnology
1598 news stories found
Press Release
September 29, 2026
An integrated workflow links glycoprotein design and production with analytical strategies for investigating glycosylation heterogeneity and structural variation.
Read Press Release
Press Release
September 25, 2026
Creative Biolabs today announced the availability of its therapeutic antibody engineering services.
Read Press Release
Press Release
September 25, 2026
Creative Biolabs expands its CAR/TCR development capabilities with AI-driven solutions designed to support receptor candidate screening, prioritize engineered T-cell designs, and identify potential safety and specificity risks earlier in development.
Read Press Release
Press Release
September 24, 2026
Creative Biolabs has expanded its specialized antibody portfolio targeting structural and envelope proteins from HIV-1, HIV-2, and HTLV-1.
Read Press Release
Press Release
September 24, 2026
Creative Biolabs officially announced today the expansion of its plant-derived extracellular vesicle development platform to support advancing research in natural nanoscale delivery systems.
Read Press Release
Press Release
September 17, 2026
Creative Biolabs, a global CRO specializing in antibody-drug conjugates (ADCs), is highlighting its integrated bispecific and biparatopic ADC development capabilities.
Read Press Release
Press Release
September 15, 2026
Creative Biolabs boosts biotherapeutics research by combining specialized immunology assays with advanced microfluidics to help researchers profile immune responses and build flexible, fit‑for‑purpose workflows.
Read Press Release
Press Release
September 11, 2026
Creative Biolabs expands functionalized lipid-based delivery system development capabilities, helping researchers address persistent challenges in targeting, carrier stability, biological responsiveness, and controlled payload release.
Read Press Release
Press Release
September 10, 2026
Clinical Trial Update on Redsenol-1 Plus for Cancer-Related Fatigue Research
Read Press Release
Press Release
September 9, 2026
Creative Biolabs has expanded its single-cell analysis capabilities to support increasingly complex biomedical research applications.
Read Press Release
Press Release
September 3, 2026
More than 100 attendees, including state and local dignitaries, were on hand for the official launch of its solar-powered ozone treatment facility
Read Press Release
Press Release
August 27, 2026
Creative Biolabs updates its in vivo CAR-T development portfolio, providing viral and non-viral research options to support studies addressing delivery, manufacturing, and preclinical development challenges.
Read Press Release
Press Release
August 25, 2026
Creative Biolabs will host a live webinar, "Modeling T Cell Dysfunction in Tumor Microenvironments," on September 1, 2026, at 10:00 AM EDT.
Read Press Release
Press Release
August 20, 2026
Creative Biolabs expands its complement assay portfolio to include C3b deposition, haemolysis inhibition, and individual complement component activity testing in support of complement-focused drug discovery and preclinical research.
Read Press Release
Press Release
August 18, 2026
Redesigned site streamlines booking, highlights insurance coverage, and outlines core specialty programs.
Read Press Release
Press Release
August 14, 2026
20 Years of Impact: Expanding Patient Access and Accelerating Innovation
Read Press Release
Press Release
August 12, 2026
Creative Biolabs, a premier global CRO, today announced the expansion of its preclinical development pipeline specifically engineered for complex LBPs.
Read Press Release
Press Release
July 30, 2026
Dr. Tansey is a serial entrepreneur, research academic and business leader with extensive experience in life sciences, technology commercialization, fundraising and corporate governance.
Read Press Release
Press Release
July 28, 2026
Project goal is to expand yeast-based RNAi biopesticide platform technology applications to the many global agricultural pests living below ground
Read Press Release
Press Release
July 23, 2026
Creative Biolabs has expanded its integrated microfluidics portfolio with droplet generation systems, microfluidic chips, and antibody development solutions to advance high-throughput biologics research.
Read Press Release